Droxidopa: all 38 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes DiseaseRecruitingNCT07398508Phase 1/2
• Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney InjuryRecruitingNCT06937307Phase 2
• Droxidopa / Pyridostigmine in Orthostatic HypotensionEnrolling by invitationNCT01370512Phase 2
• NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn SyndromeCompletedNCT04977388Phase 1/2Results posted
• Lundbeck TOMs Orthostatic HypotensionCompletedNCT04510922Phase 4Results posted
• Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord InjuryCompletedNCT03602014Phase 4Results posted
• Norepinephrine-targeted Therapy for Action Control in Parkinson DiseaseCompletedNCT03115827Phase 4Results posted
• Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And AntagonistTerminatedNCT03070730Phase 1/2Results posted
• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic HypotensionCompletedNCT02586623Phase 4Results posted
• A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3Results posted
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3Results posted
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3Results posted
• Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of CarbidopaCompletedNCT00983814Phase 2Results posted
• Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue SyndromeTerminatedNCT00977171Phase 2Results posted
• A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3Results posted
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3Results posted
• Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic HypotensionCompletedNCT00657046Phase 2Results posted
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3Results posted
• Treatment of Orthostatic HypotensionTerminatedNCT00581477Phase 2/3Results posted
• Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedNCT00547911Phase 1/2Results posted
• Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)Status unknownNCT03567447Phase 2
• Safety and Efficacy of Droxidopa for Fatigue in Patients With ParkinsonismWithdrawnNCT03446807Phase 2
• Brain Perfusion & Oxygenation in Parkinson's Disease With NOHCompletedNCT03229174Phase 4
• Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's DiseaseCompletedNCT03173781Not applicable
• A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's DiseaseTerminatedNCT03034564Phase 4
• Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureTerminatedNCT02897063Phase 1
• Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson DiseaseStatus unknownNCT02812147Phase 2
• A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and AnhidrosisWithdrawnNCT02624310Phase 2
• Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSACompletedNCT02071459Phase 2/3
• Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's DiseaseStatus unknownNCT02066571Phase 2
• Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis PatientsTerminatedNCT01612078Phase 3
• A Multi-Center, Open-Label StudyWithdrawnNCT01468259Phase 1
• A Dose Titration of Droxidopa in Patients With Spinal Cord InjuryCompletedNCT01354158Phase 1
• Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's DiseaseWithdrawnNCT01331122Phase 1/2
• Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic DoseCompletedNCT01327066Phase 1
• Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With FibromyalgiaCompletedNCT01323374Phase 2
• Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of DroxidopaCompletedNCT01149629Phase 1
• Droxidopa in Treating Patients With Neurogenic HypotensionCompletedNCT00004478Not applicable

← Droxidopa overview